Acta Neurologica Scandinavica

Cover image for Vol. 127 Issue 2

February 2013

Volume 127, Issue 2

Pages 77–147, e5–e12

  1. Review article

    1. Top of page
    2. Review article
    3. Original articles
    4. Clinical commentary
    1. rTMS as a treatment for neurogenic communication and swallowing disorders (pages 77–91)

      C. H. S. Barwood and B. E. Murdoch

      Version of Record online: 9 AUG 2012 | DOI: 10.1111/j.1600-0404.2012.01710.x

  2. Original articles

    1. Top of page
    2. Review article
    3. Original articles
    4. Clinical commentary
    1. Risk factor burden predicts long-term mortality in young patients with arterial cerebral infarction (pages 92–96)

      H. Naess, U. Waje-Andreassen and H. Nyland

      Version of Record online: 23 MAY 2012 | DOI: 10.1111/j.1600-0404.2012.01681.x

    2. A revised intracarotid etomidate memory (Wada) procedure (pages 97–102)

      F. Andelman, S. Kipervasser, S. Maimon, I. Fried, Y. Parmet and M. Y. Neufeld

      Version of Record online: 1 JUN 2012 | DOI: 10.1111/j.1600-0404.2012.01685.x

    3. Ketogenic diet effects on cognition, mood, and psychosocial adjustment in children (pages 103–108)

      D. A. J. E. Lambrechts, M. J. M. Bovens, N. M. de la Parra, J. G. M. Hendriksen, A. P. Aldenkamp and M. J. M. Majoie

      Version of Record online: 12 JUN 2012 | DOI: 10.1111/j.1600-0404.2012.01686.x

    4. IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy (pages 109–115)

      M. Vrethem, J. Lindh, M. Tondel, B. Persson and C. Dahle

      Version of Record online: 1 JUN 2012 | DOI: 10.1111/j.1600-0404.2012.01687.x

    5. Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers (pages 124–132)

      D. Nyholm, M. Ehrnebo, T. Lewander, C. G. Trolin, T. Bäckström, G. Panagiotidis, J. Spira, C. Nyström and S.-M. Aquilonius

      Version of Record online: 4 JUL 2012 | DOI: 10.1111/j.1600-0404.2012.01700.x

    6. Stoppers and non-starters of disease-modifying treatment in multiple sclerosis (pages 133–140)

      N. Grytten, J. H. Aarseth, K. Espeset, G. B. Johnsen, R. Wehus, C. Lund and R. C. Haugstad

      Version of Record online: 25 AUG 2012 | DOI: 10.1111/j.1600-0404.2012.01708.x

    7. Prediction for relapse and prognosis of newly diagnosed epilepsy (pages 141–147)

      L. Su, Q. Di, P. Kwan, N. Yu, Y. Zhang, Y. Hu and L. Gao

      Version of Record online: 8 AUG 2012 | DOI: 10.1111/j.1600-0404.2012.01711.x

  3. Clinical commentary

    1. Top of page
    2. Review article
    3. Original articles
    4. Clinical commentary
    1. Neurologic safety event rates in the SENTIS trial control population (pages e5–e7)

      H. L. Lutsep, I. M. Altafullah, R. Roberts, I. E. Silverman, M. A. Turco and A. G. Vaishnav

      Version of Record online: 18 SEP 2012 | DOI: 10.1111/ane.12005

    2. Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies (pages e8–e12)

      R. Constantinescu, U. Andreasson, B. Holmberg and H. Zetterberg

      Version of Record online: 23 SEP 2012 | DOI: 10.1111/ane.12012